Stock data
Prime Medicine, Inc. (PRME)
Prime Medicine, Inc. (PRME) reported revenue of US$4.63M and net income of -US$201.14M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$4.63M | — | -US$208.35M | -US$201.14M | — |
| 2024 | US$2.98M | — | -US$202.47M | -US$195.88M | — |
| 2023 | US$0.00M | — | -US$204.79M | -US$198.13M | — |
| 2022 | US$0.00M | — | -US$116.54M | -US$121.82M | — |
| 2021 | US$0.00M | — | -US$84.47M | -US$165.37M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$42.11M | — |
| 2026-03-31 | — | -US$49.12M | — |
| 2025-12-31 | US$0.84M | -US$46.08M | — |
| 2025-09-30 | US$1.23M | -US$50.58M | — |
| 2025-06-30 | US$1.11M | -US$52.59M | — |
| 2025-03-31 | US$1.45M | -US$51.89M | — |
| 2024-12-31 | US$2.18M | -US$42.28M | — |
| 2024-09-30 | US$0.21M | -US$52.52M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.